Intestinal pseudo-obstruction caused by neuromyopathy in a patient with systemic sclerosis

Modern Rheumatology

Volumn 22, Issue 6, 2012, Pages 912-918

  Park, Jin Sun ^a   Kim, Hyoun Ah ^a   Lee, Kwang Jae ^a   Suh, Chang Hee ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

Electrogastrography; Intestinal pseudo obstruction; Small bowel manometry; Systemic sclerosis

Indexed keywords

BUCILLAMINE; ERYTHROMYCIN; ITOPRIDE; METHYLPREDNISOLONE; PREDNISOLONE; SULPIRIDE; TEGASEROD;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ADULT; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; ELECTROGASTROGRAPHY; FEMALE; HUMAN; INTESTINE CONTRACTION; INTESTINE OBSTRUCTION; INTESTINE PSEUDO OBSTRUCTION; MANOMETRY; MEDICAL HISTORY; NAUSEA; NEUROMUSCULAR DISEASE; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS; VOMITING;

EID: 84870380191     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-012-0597-x     Document Type: Article

References (15)

1. Lock G, Holstege A, Lang B, Scholmerich J. Gastrointestinal manifestations of progressive systemic sclerosis. Am J Gastroenterol. 1997;92:763-71.
2. Weston S, Thumshirn M, Wiste J, Carnilleri M. Clinical upper gastrointestinal motility features in systemic sclerosis and related disorders. Am J Gatroenterol. 1998;93:1085-9.
3. Varga J, Denton CP. Systemic Sclerosis and the Scleroderma-Spectrum Disorders. In: Firestein GS, Budd RC, Harris ED, McInnes IB, Ruddy S, Sergent JS, editors. Kelley's textbook of rheumatology. 8th ed. Philadelphia: Elsevier Saunders; 2008. 1311-51.
4. Sjogren RW. Gastrointestinal motility disorders in scleroderma. Arthritis Rheum. 1994;37:1265-82.
5. Marie I, Levesque H, Ducrotté P, Denis P, Benichou J, Hellot MF, et al. Manometry of the upper intestinal tract in patients with systemic sclerosis: a prospective study. Arthritis Rheum. 1998; 41:1874-83.
6. Ponge T, Bruley des Varannes S. Digestive involvement of scleroderma. Rev Prat. 2002;52:1896-900.
7. Forbes A, Marie I. Gastrointestinal complications: the most frequent internal complications of systemic sclerosis. Rheumatology (Oxford) 2009; 48 (Suppl 3):iii36-9.
8. Jaovisidha K, Csuka ME, Almagro UA, Soergel KH. Severe gastrointestinal involvement in systemic sclerosis: report of five cases and review of the literature. Semin Arthritis Rheum. 2005;34(4):689-702.
9. Wigley FM, Hummers LK. Clinical features of systemic sclerosis. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH, editors. Practical rheumatology. 3rd ed. Philadelphia: Mosby; 2004. p. 449-65.
10. Sjogren RW. Gastrointestinal features of scleroderma. Curr Opin Rheumatol. 1996;8:569-75.
11. Wollaston DE, Xu X, Tokumaru O, Chen JD, McNearney TA. Patients with systemic sclerosis have unique and persistent alterations in gastric myoelectrical activity with acupressure to Neiguan point PC6. J Rheumatol. 2005;32:494-501.
12. Turner R, Lipshutz W, Miller W, Rittenberg G, Schumacher HR, Chohen S. Esophageal dysfunction in collagen disease. Am J Med Sci. 1973;265:191-9.
13. McNearney TA, Sallam HS, Hunnicutt SE, Doshi D, Wollaston DE, Mayes MD, et al. Gastric slow waves, gastrointestinal symptoms and peptides in systemic sclerosis patients. Neurogastroenterol Motil 2009;21(12):1269-e120.
14. Kawaguchi Y, Nakamura Y, Matsumoto I, Nishimagi E, Satoh T, Kuwana M, Sumida T, Hara M. Muscarinic-3 acetylcholine receptor autoantibody in patients with systemic sclerosis: contribution to severe gastrointestinal tract dysmotility. Ann Rheum Dis. 2009;68:710-4.
15. Nishimagi E, Tochimoto A, Kawaguchi Y, Satoh T, Kuwana M, Takagi K, Ichida H, Kanno T, Soejima M, Baba S, Kamatani N, Hara M. Characteristics of patients with early systemic sclerosis and severe gastrointestinal tract involvement. J Rheumatol. 2007;34:2050-5.